Analytical methods | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Chromatography | LC | LC | |
Ion source | ESI | ESI | |
Positive/Negative mode | negative | positive | |
Mass analyzer | Q-Orbitrap | Q-Orbitrap | |
Identification level | MS/MS | MS/MS |
Sample information | |||
---|---|---|---|
Comparative study | #1 | #2 | |
Country | China | China | |
Specimen | plasma | plasma | |
Marker function | diagnosis | diagnosis | |
Participants(Case) | Cancer type | lung cancer | lung cancer |
Stage | – | – | |
Number | 31 | 31 | |
Gender (M,F) | 19, 12 | 19, 12 | |
Mean age (range) (M,F) | 28-64 | 28-64 | |
Smoking status | – | – | |
Participants(Control) | Type | healthy | healthy |
Number | 35 | 35 | |
Gender (M,F) | 24, 11 | 24, 11 | |
Mean age (range) (M,F) | 23-60 | 23-60 | |
Smoking status | – | – |
Data processing and metabolite identification | |
---|---|
Data processing software | XCMS |
Database search | OSI-SMMS |
Statistical analysis | |
---|---|
Differential analysis method | OPLS-DA, Mann-Whitney U test |
Classification method | – |
Survival analysis method | – |
Metabolite | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|
L-cysteine-glutathione gisulfide | – | – | – | 3.19 | 2.01e-06 | – | 1.94 |
2, 4-diacetylphloroglucinol | – | – | – | 2.78 | 1.17e-11 | – | 2.65 |
glycoursodeoxycholic acid | – | – | – | 1.88 | 7.35e-03 | – | 1.26 |
glycoursodeoxycholic acid | – | – | – | 1.70 | 8.75e-03 | – | 1.20 |
phenylalanine | – | – | – | 1.58 | 1.15e-04 | – | 1.32 |
2,3-dihydroxybenzoic acid | – | – | – | 1.53 | 1.76e-04 | – | 1.52 |
stearamide | – | – | – | 1.46 | 1.42e-03 | – | 1.29 |
6-thioxanthine | – | – | – | 1.36 | 2.42e-04 | – | 1.27 |
D-mannose | – | – | – | 1.35 | 6.99e-05 | – | 1.82 |
Dl-P-hydroxyphenyl lactic acid | – | – | – | 1.32 | 4.04e-03 | – | 1.40 |
D(-)-arginine | – | – | – | 1.30 | 4.56e-04 | – | 1.29 |
hydroxyphenyllactic acid | – | – | – | 1.30 | 0.01 | – | 1.30 |
3-carboxybenzadehyde | – | – | – | 1.25 | 1.49e-03 | – | 1.42 |
L-tyrosine | – | – | – | 1.25 | 0.01 | – | 1.30 |
2-methylmercaptobenzothiazole | – | – | – | 0.89 | 1.68e-03 | – | 1.22 |
alpha-pinene | – | – | – | 0.88 | 5.51e-05 | – | 1.74 |
dodecylamine | – | – | – | 0.86 | 1.82e-03 | – | 1.48 |
cholesteryl laurate | – | – | – | 0.83 | 6.37e-03 | – | 1.22 |
xanthine | V | – | – | 0.80 | 3.13e-07 | – | 1.89 |
calcifediol | – | – | – | 0.76 | 1.29e-03 | – | 1.32 |
D-pantothenic acid | – | – | – | 0.73 | 3.68e-03 | – | 1.30 |
pyroglutamic acid | – | – | – | 0.69 | 9.47e-04 | – | 1.72 |
malic acid | – | – | – | 0.69 | 7.49e-04 | – | 1.41 |
uridine | – | – | – | 0.68 | 1.11e-04 | – | 1.84 |
4-pyridoxate | V | – | – | 0.66 | 7.47e-05 | – | 1.31 |
cis-11,14-eicosadienoic acid | – | – | – | 0.66 | 1.68e-03 | – | 1.51 |
D-(+)-Malic acid | – | – | – | 0.64 | 9.16e-08 | – | 2.03 |
cis-8,11,14-eicosatrienoic acid | – | – | – | 0.64 | 4.41e-04 | – | 1.42 |
docosahexaenoic acid | – | – | – | 0.58 | 2.73e-04 | – | 1.67 |
threonate | – | – | – | 0.57 | 1.02e-06 | – | 2.06 |
3-aminopentanedioic acid | – | – | – | 0.56 | 2.21e-08 | – | 2.13 |
10-hydroxydecanoic acid | – | – | – | 0.55 | 3.94e-05 | – | 1.85 |
7z,10z,13z-hexadecatrienoic acid | – | – | – | 0.55 | 7.96e-04 | – | 1.46 |
arachidonic acid | – | – | – | 0.54 | 5.11e-06 | – | 1.97 |
Dl-glutamic acid | – | – | – | 0.54 | 1.15e-08 | – | 2.17 |
All-cis-4,7,10,13,16-docosapentaenoic acid | – | – | – | 0.53 | 4.22e-04 | – | 1.59 |
canthaxanthine | – | – | – | 0.53 | 1.28e-04 | – | 1.68 |
L-pyroglutamic acid | – | – | – | 0.52 | 8.00e-07 | – | 2.07 |
Phe-Phe | – | – | – | 0.49 | 9.42e-05 | – | 1.82 |
10-undecenoic acid | – | – | – | 0.44 | 1.91e-06 | – | 2.14 |
2-aminopropanol | – | – | – | 0.44 | 0.02 | – | 1.48 |
D-Glu | V | – | – | 0.42 | 4.05e-03 | – | 1.75 |
5-pregnane-3,20-dione | – | – | – | 0.42 | 0.04 | – | 1.58 |
butylamine | – | – | – | 0.41 | 2.38e-08 | – | 2.08 |
glycerophosphoric acid | – | – | – | 0.32 | 1.17e-08 | – | 2.59 |
3-methylcrotonyl glycine | – | – | – | 0.29 | 9.85e-03 | – | 1.59 |
hypoxanthine | – | – | – | 0.28 | 1.83e-07 | – | 2.43 |
8(R)-hydroxy-(5Z,9E,11Z,14Z)-eicosatetraenoic acid | – | – | – | 0.27 | 1.08e-04 | – | 2.33 |
hypoxanthine | – | – | – | 0.24 | 2.12e-07 | – | 2.69 |
inosine | – | – | – | 0.20 | 6.44e-06 | – | 2.34 |
N-oleoylethanolamine | – | – | – | 0.05 | 1.07e-07 | – | 2.56 |
inosine | – | – | – | 0.03 | 1.99e-04 | – | 2.01 |
N-acetyl-5-hydroxytryptamine | – | – | – | 0.02 | 5.37e-08 | – | 2.44 |
Metabolite | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|
L-cysteine-glutathione gisulfide | – | – | – | – | – | – |
2, 4-diacetylphloroglucinol | – | – | – | – | – | – |
glycoursodeoxycholic acid | – | – | – | – | – | – |
glycoursodeoxycholic acid | – | – | – | – | – | – |
phenylalanine | – | – | – | – | – | – |
2,3-dihydroxybenzoic acid | – | – | – | – | – | – |
stearamide | – | – | – | – | – | – |
6-thioxanthine | – | – | – | – | – | – |
D-mannose | – | – | – | – | – | – |
Dl-P-hydroxyphenyl lactic acid | – | – | – | – | – | – |
D(-)-arginine | – | – | – | – | – | – |
hydroxyphenyllactic acid | – | – | – | – | – | – |
3-carboxybenzadehyde | – | – | – | – | – | – |
L-tyrosine | – | – | – | – | – | – |
2-methylmercaptobenzothiazole | – | – | – | – | – | – |
alpha-pinene | – | – | – | – | – | – |
dodecylamine | – | – | – | – | – | – |
cholesteryl laurate | – | – | – | – | – | – |
xanthine | V | – | – | – | – | – |
calcifediol | – | – | – | – | – | – |
D-pantothenic acid | – | – | – | – | – | – |
pyroglutamic acid | – | – | – | – | – | – |
malic acid | – | – | – | – | – | – |
uridine | – | – | – | – | – | – |
4-pyridoxate | V | – | – | – | – | – |
cis-11,14-eicosadienoic acid | – | – | – | – | – | – |
D-(+)-Malic acid | – | – | – | – | – | – |
cis-8,11,14-eicosatrienoic acid | – | – | – | – | – | – |
docosahexaenoic acid | – | – | – | – | – | – |
threonate | – | – | – | – | – | – |
3-aminopentanedioic acid | – | – | – | – | – | – |
10-hydroxydecanoic acid | – | – | – | – | – | – |
7z,10z,13z-hexadecatrienoic acid | – | – | – | – | – | – |
arachidonic acid | – | – | – | – | – | – |
Dl-glutamic acid | – | – | – | – | – | – |
All-cis-4,7,10,13,16-docosapentaenoic acid | – | – | – | – | – | – |
canthaxanthine | – | – | – | – | – | – |
L-pyroglutamic acid | – | – | – | – | – | – |
Phe-Phe | – | – | – | – | – | – |
10-undecenoic acid | – | – | – | – | – | – |
2-aminopropanol | – | – | – | – | – | – |
D-Glu | V | – | – | – | – | – |
5-pregnane-3,20-dione | – | – | – | – | – | – |
butylamine | – | – | – | – | – | – |
glycerophosphoric acid | – | – | – | – | – | – |
3-methylcrotonyl glycine | – | – | – | – | – | – |
hypoxanthine | – | – | – | – | – | – |
8(R)-hydroxy-(5Z,9E,11Z,14Z)-eicosatetraenoic acid | – | – | – | – | – | – |
hypoxanthine | – | – | – | – | – | – |
inosine | – | – | – | – | – | – |
N-oleoylethanolamine | – | – | – | – | – | – |
inosine | – | – | – | – | – | – |
N-acetyl-5-hydroxytryptamine | – | – | – | – | – | – |